Supplemental Oxygen and Complications After Abdominal Surgery (The PROXI-trial)

NCT ID: NCT00364741

Last Updated: 2009-10-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

1400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-10-31

Study Completion Date

2008-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim: To investigate the effect of high intra- and postoperative oxygen concentration (80%, as opposed to normally 30%) on surgical wound infection and pulmonary complications after abdominal surgery.

Background: Surgical wound infection is a common and serious complication. Tissue oxygen tension is often low after surgery and the resistance against infection depends on this factor through bacterial killing by neutrophils. Oxygen is a substrate in this reaction, and it is hypothesized that by increasing the arterial oxygen tension, the risk of surgical wound infection is reduced. Previous studies to test this hypothesis have shown entirely different results. Hence, the clinical decision between high and normal oxygen concentration is still controversial.

Primary hypothesis of study: Use of 80% oxygen decreases the incidence of surgical wound infection after abdominal surgery.

Secondary objectives: To investigate the effect 80% oxygen on pulmonary complications (atelectasis, pneumonia, respiratory insufficiency), second operation, mortality and length of postoperative hospitalization and admission to intensive care unit after abdominal surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laparotomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Fraction of inspired oxygen (FiO2) = 0.30

Group Type ACTIVE_COMPARATOR

Oxygen

Intervention Type DRUG

During and 2 hours after surgery

B

FiO2 = 0.80

Group Type ACTIVE_COMPARATOR

Oxygen

Intervention Type DRUG

During and 2 hours after surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oxygen

During and 2 hours after surgery

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years or older.
* Laparotomy, acute or elective. In case of gynaecological surgery only if malignancy is suspected (defined as risk of ovarian malignancy index \>200 or a specimen with atypical or neoplastic cells).

Exclusion Criteria

* Other surgery within 30 days (except surgery in local anaesthesia).
* Chemotherapy within 3 months.
* Inability to give informed consent.
* Inability to keep oxygen saturation above 90% without supplemental oxygen (measured preoperatively by pulse oximetry).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Danish Medical Research Council

OTHER

Sponsor Role collaborator

Rigshospitalet, Denmark

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of Anaesthesia, HOC, Copenhagen University Hospital, Rigshospitalet

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lars S. Rasmussen, MD,DMSc,PHD

Role: STUDY_CHAIR

Dept. of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Jørn Wetterslev, MD, PHD

Role: STUDY_DIRECTOR

Copenhagen Trial Unit, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Lars N. Jørgensen, MD, DMSc

Role: STUDY_DIRECTOR

Dept. of Surgery, Copenhagen University Hospital, Bispebjerg, Copenhagen, Denmark

Christian S. Meyhoff, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Dept. of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Aarhus Sygehus

Aarhus, , Denmark

Site Status

Copenhagen University Hospital, Rigshospitalet

Copenhagen, , Denmark

Site Status

Copenhagen University Hospital, Amager

Copenhagen, , Denmark

Site Status

Copenhagen University Hospital, Bispebjerg

Copenhagen, , Denmark

Site Status

Copenhagen University Hospital, Gentofte

Hellerup, , Denmark

Site Status

Copenhagen University Hospital, Herlev

Herlev, , Denmark

Site Status

Holbaek Hospital

Holbæk, , Denmark

Site Status

Kolding Hospital

Kolding, , Denmark

Site Status

Nykoebing Falster Hospital

Nykoebing Falster, , Denmark

Site Status

Naestved Hospital

Næstved, , Denmark

Site Status

Slagelse Hospital

Slagelse, , Denmark

Site Status

Funen County Hospital

Svendborg, , Denmark

Site Status

Vejle Hospital

Vejle, , Denmark

Site Status

Viborg Hospital

Viborg, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

References

Explore related publications, articles, or registry entries linked to this study.

Meyhoff CS, Wetterslev J, Jorgensen LN, Henneberg SW, Simonsen I, Pulawska T, Walker LR, Skovgaard N, Helto K, Gocht-Jensen P, Carlsson PS, Rask H, Karim S, Carlsen CG, Jensen FS, Rasmussen LS; PROXI Trial Group. Perioperative oxygen fraction - effect on surgical site infection and pulmonary complications after abdominal surgery: a randomized clinical trial. Rationale and design of the PROXI-Trial. Trials. 2008 Oct 22;9:58. doi: 10.1186/1745-6215-9-58.

Reference Type BACKGROUND
PMID: 18945347 (View on PubMed)

Meyhoff CS, Wetterslev J, Jorgensen LN, Henneberg SW, Hogdall C, Lundvall L, Svendsen PE, Mollerup H, Lunn TH, Simonsen I, Martinsen KR, Pulawska T, Bundgaard L, Bugge L, Hansen EG, Riber C, Gocht-Jensen P, Walker LR, Bendtsen A, Johansson G, Skovgaard N, Helto K, Poukinski A, Korshin A, Walli A, Bulut M, Carlsson PS, Rodt SA, Lundbech LB, Rask H, Buch N, Perdawid SK, Reza J, Jensen KV, Carlsen CG, Jensen FS, Rasmussen LS; PROXI Trial Group. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA. 2009 Oct 14;302(14):1543-50. doi: 10.1001/jama.2009.1452.

Reference Type RESULT
PMID: 19826023 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GCP-2006-101

Identifier Type: -

Identifier Source: secondary_id

KF 02 306766

Identifier Type: -

Identifier Source: secondary_id

2006-001710-32

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.